Abstract
Plasma biomarkers pertaining to the underlying pathophysiology of Alzheimer’s disease have recently become available (for example, amyloid beta and phosphorylated tau).
| Original language | English (US) |
|---|---|
| Pages (from-to) | 94-96 |
| Number of pages | 3 |
| Journal | Nature Aging |
| Volume | 2 |
| Issue number | 2 |
| DOIs |
|
| State | Published - Feb 2022 |
ASJC Scopus subject areas
- Neuroscience (miscellaneous)
- Aging
- Geriatrics and Gerontology
Fingerprint
Dive into the research topics of 'Are plasma markers for Alzheimer’s disease ready for clinical use?'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS